About Carigent Therapeutics
Carigent Therapeutics is a Healthcare company based in United States founded in 2007. Next-generation therapeutic agents are developed via a proprietary controlled-release platform. Carigent Therapeutics offers products and services including Proprietary Platform and Therapeutic Agents. Its focus areas include Life Sciences, Imaging Diagnostics and Accessories. Its legal entity is Carigent Technologies.
Company details
Carigent Therapeutics was founded in 2007 and is based in the United States. Operations focus on the biotechnology sector, where next-generation therapeutic agents are created using a proprietary controlled-release platform. This technology supports controlled release of agents, surface ligand attachment, targeted delivery to specific sites, and integration of multiple agents into a single FDA-approved vehicle. Versatility is provided for developing various therapeutics.
- Headquarters United States
- SectorsHealthcare
- Website carigent.com
- Legal Name Carigent Technologies
- Latest Funding Round$204.34K (USD), Grant
Sep 2016
- InvestorsHHS
& 1 more
Products & Services of Carigent Therapeutics
Carigent Therapeutics offers a comprehensive portfolio of products and services, including Proprietary Platform and Therapeutic Agents.
A platform is utilized for the development of therapeutic agents, including controlled release and targeting features.
Agents are developed for various applications, incorporating surface ligands and multiple components from FDA-approved materials.
Funding Insights of Carigent Therapeutics
- Total Rounds 4
- Last Round Grant — $204,344
- First Round $97,021
(Nov 2007)
- Investors Count 2
All 4 funding rounds of Carigent Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2016 | $204,344 | Grant | – | – | |
| Jan 2016 | $97,021 | Grant | – | – | |
| Sep 2008 | $204,344 | Grant | – | – | |
| Nov 2007 | $97,021 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Carigent Therapeutics
Carigent Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Carigent Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Carigent Therapeutics
3 dated milestones of Carigent Therapeutics across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Carigent Therapeutics is founded.
- Funding First funding round of $97K.
- Funding Latest funding round, Grant, of $204K.
Top companies in Imaging Diagnostics
3 companies that operate in the same segment as Carigent Therapeutics (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Carigent Therapeutics
Carigent Therapeutics was founded in 2007.
Carigent Therapeutics is headquartered in United States.
Carigent Therapeutics was founded in 2007 and is based in the United States. Operations focus on the biotechnology sector, where next-generation therapeutic agents are created using a proprietary controlled-release platform. This technology supports controlled release of agents, surface ligand attachment, targeted delivery to specific sites, and integration of multiple agents into a single FDA-approved vehicle. Versatility is provided for developing various therapeutics.
Carigent Therapeutics offers Proprietary Platform and Therapeutic Agents.
Carigent Therapeutics has 2 investors. Key investors include HHS, and National Science Foundation.
Carigent Therapeutics operates through Carigent Technologies.